vs
Purple Innovation, Inc.（PRPL）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
Purple Innovation, Inc.的季度营收约是再鼎医药的1.1倍（$140.7M vs $127.1M），再鼎医药同比增速更快（17.1% vs 9.1%），Purple Innovation, Inc.自由现金流更多（$-7.8M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 8.3%）
Purple Carrot是一家总部位于马萨诸塞州尼达姆市的全植物性餐包品牌，由安迪·莱维特创立，每周为订阅用户提供预制餐品和自制餐包。据《大都会》2022年报道，对比美式标准餐食，该品牌每份餐包的碳排放量可降低72%，主打低碳环保的纯植物饮食方案。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
PRPL vs ZLAB — 直观对比
营收规模更大
PRPL
是对方的1.1倍
$127.1M
营收增速更快
ZLAB
高出8.0%
9.1%
自由现金流更多
PRPL
多$18.9M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
8.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $140.7M | $127.1M |
| 净利润 | $-3.2M | — |
| 毛利率 | 41.9% | 51.0% |
| 营业利润率 | -1.6% | -54.6% |
| 净利率 | -2.3% | — |
| 营收同比 | 9.1% | 17.1% |
| 净利润同比 | 62.1% | — |
| 每股收益（稀释后） | $0.03 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRPLZLAB
| Q4 25 | $140.7M | $127.1M | ||
| Q3 25 | $118.8M | $115.4M | ||
| Q2 25 | $105.1M | $109.1M | ||
| Q1 25 | $104.2M | $105.7M | ||
| Q4 24 | $129.0M | $108.5M | ||
| Q3 24 | $118.6M | $101.8M | ||
| Q2 24 | $120.3M | $100.1M | ||
| Q1 24 | $120.0M | $87.1M |
净利润PRPLZLAB
| Q4 25 | $-3.2M | — | ||
| Q3 25 | $-11.7M | $-36.0M | ||
| Q2 25 | $-17.3M | $-40.7M | ||
| Q1 25 | $-19.1M | $-48.4M | ||
| Q4 24 | $-8.5M | — | ||
| Q3 24 | $-39.2M | $-41.7M | ||
| Q2 24 | $27.0K | $-80.3M | ||
| Q1 24 | $-50.2M | $-53.5M |
毛利率PRPLZLAB
| Q4 25 | 41.9% | 51.0% | ||
| Q3 25 | 42.8% | 59.5% | ||
| Q2 25 | 35.9% | 60.6% | ||
| Q1 25 | 39.4% | 63.6% | ||
| Q4 24 | 42.9% | 61.5% | ||
| Q3 24 | 29.7% | 64.1% | ||
| Q2 24 | 40.7% | 64.9% | ||
| Q1 24 | 34.8% | 61.4% |
营业利润率PRPLZLAB
| Q4 25 | -1.6% | -54.6% | ||
| Q3 25 | -10.2% | -42.3% | ||
| Q2 25 | -13.5% | -50.3% | ||
| Q1 25 | -13.9% | -53.3% | ||
| Q4 24 | -6.0% | -62.6% | ||
| Q3 24 | -39.5% | -66.6% | ||
| Q2 24 | -12.1% | -76.0% | ||
| Q1 24 | -19.3% | -80.7% |
净利率PRPLZLAB
| Q4 25 | -2.3% | — | ||
| Q3 25 | -9.9% | -31.2% | ||
| Q2 25 | -16.5% | -37.3% | ||
| Q1 25 | -18.4% | -45.8% | ||
| Q4 24 | -6.6% | — | ||
| Q3 24 | -33.1% | -40.9% | ||
| Q2 24 | 0.0% | -80.2% | ||
| Q1 24 | -41.8% | -61.4% |
每股收益（稀释后）PRPLZLAB
| Q4 25 | $0.03 | $-0.05 | ||
| Q3 25 | $0.11 | $-0.03 | ||
| Q2 25 | $0.16 | $-0.04 | ||
| Q1 25 | $0.18 | $-0.04 | ||
| Q4 24 | $0.08 | $-0.09 | ||
| Q3 24 | $0.36 | $-0.04 | ||
| Q2 24 | $0.00 | $-0.08 | ||
| Q1 24 | $0.47 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.3M | $689.6M |
| 总债务越低越好 | $126.7M | — |
| 股东权益账面价值 | $-29.7M | $715.5M |
| 总资产 | $296.3M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PRPLZLAB
| Q4 25 | $24.3M | $689.6M | ||
| Q3 25 | $32.4M | $717.2M | ||
| Q2 25 | $34.2M | $732.2M | ||
| Q1 25 | $21.6M | $757.3M | ||
| Q4 24 | $29.0M | $779.7M | ||
| Q3 24 | $23.4M | $616.1M | ||
| Q2 24 | $23.4M | $630.0M | ||
| Q1 24 | $34.5M | $650.8M |
总债务PRPLZLAB
| Q4 25 | $126.7M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $70.7M | — | ||
| Q3 24 | $50.8M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益PRPLZLAB
| Q4 25 | $-29.7M | $715.5M | ||
| Q3 25 | $-26.9M | $759.9M | ||
| Q2 25 | $-15.6M | $791.7M | ||
| Q1 25 | $1.3M | $810.8M | ||
| Q4 24 | $20.2M | $840.9M | ||
| Q3 24 | $28.0M | $667.7M | ||
| Q2 24 | $66.4M | $704.2M | ||
| Q1 24 | $65.5M | $762.2M |
总资产PRPLZLAB
| Q4 25 | $296.3M | $1.2B | ||
| Q3 25 | $302.1M | $1.2B | ||
| Q2 25 | $303.8M | $1.2B | ||
| Q1 25 | $293.8M | $1.2B | ||
| Q4 24 | $307.8M | $1.2B | ||
| Q3 24 | $309.3M | $985.3M | ||
| Q2 24 | $362.1M | $987.4M | ||
| Q1 24 | $382.1M | $988.4M |
负债/权益比PRPLZLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.50× | — | ||
| Q3 24 | 1.82× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.8M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $-7.8M | $-26.7M |
| 自由现金流率自由现金流/营收 | -5.5% | -21.0% |
| 资本支出强度资本支出/营收 | 1.4% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-41.9M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流PRPLZLAB
| Q4 25 | $-5.8M | $-26.0M | ||
| Q3 25 | $-968.0K | $-32.0M | ||
| Q2 25 | $-4.0M | $-31.0M | ||
| Q1 25 | $-23.1M | $-61.7M | ||
| Q4 24 | $6.8M | $-55.8M | ||
| Q3 24 | $1.1M | $-26.8M | ||
| Q2 24 | $-8.9M | $-42.2M | ||
| Q1 24 | $-16.8M | $-90.1M |
自由现金流PRPLZLAB
| Q4 25 | $-7.8M | $-26.7M | ||
| Q3 25 | $-1.8M | $-35.0M | ||
| Q2 25 | $-7.0M | $-33.9M | ||
| Q1 25 | $-25.3M | $-63.2M | ||
| Q4 24 | $5.7M | $-58.4M | ||
| Q3 24 | $101.0K | $-28.2M | ||
| Q2 24 | $-11.0M | $-42.9M | ||
| Q1 24 | $-19.9M | $-91.1M |
自由现金流率PRPLZLAB
| Q4 25 | -5.5% | -21.0% | ||
| Q3 25 | -1.5% | -30.4% | ||
| Q2 25 | -6.6% | -31.1% | ||
| Q1 25 | -24.3% | -59.9% | ||
| Q4 24 | 4.4% | -53.8% | ||
| Q3 24 | 0.1% | -27.7% | ||
| Q2 24 | -9.2% | -42.9% | ||
| Q1 24 | -16.5% | -104.5% |
资本支出强度PRPLZLAB
| Q4 25 | 1.4% | 0.5% | ||
| Q3 25 | 0.7% | 2.6% | ||
| Q2 25 | 2.8% | 2.6% | ||
| Q1 25 | 2.2% | 1.5% | ||
| Q4 24 | 0.8% | 2.4% | ||
| Q3 24 | 0.9% | 1.3% | ||
| Q2 24 | 1.7% | 0.7% | ||
| Q1 24 | 2.5% | 1.1% |
现金转化率PRPLZLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -330.22× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
